Viveve Medical, Inc. (VIVE)
USD 0.0
(100.0%)
USD 0.0
(100.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2021 | 620 Thousand USD | 109.46% |
| 2020 | 296 Thousand USD | -70.87% |
| 2019 | 1.01 Million USD | -86.12% |
| 2018 | 7.32 Million USD | -1.67% |
| 2017 | 7.44 Million USD | 194.35% |
| 2016 | 2.52 Million USD | 447.4% |
| 2015 | 462 Thousand USD | 1055.0% |
| 2014 | 40 Thousand USD | -94.62% |
| 2013 | 743 Thousand USD | 37.85% |
| 2012 | 539 Thousand USD | 120.0% |
| 2011 | 245 Thousand USD | -90.34% |
| 2010 | 2.53 Million USD | -2.99% |
| 2009 | 2.61 Million USD | -16.52% |
| 2008 | 3.13 Million USD | -7.09% |
| 2007 | 3.36 Million USD | -23.67% |
| 2006 | 4.41 Million USD | -3.41% |
| 2005 | 4.57 Million USD | 1.47% |
| 2004 | 4.5 Million USD | -9.76% |
| 2003 | 4.99 Million USD | 5.16% |
| 2002 | 4.74 Million USD | 13.3% |
| 2001 | 4.18 Million USD | -39.71% |
| 2000 | 6.94 Million USD | -16.67% |
| 1999 | 8.33 Million USD | 93.91% |
| 1998 | 4.3 Million USD | -23.21% |
| 1997 | 5.6 Million USD | -37.78% |
| 1996 | 9 Million USD | -3.23% |
| 1995 | 9.3 Million USD | 244.44% |
| 1994 | 2.7 Million USD | 350.0% |
| 1993 | 600 Thousand USD | 20.0% |
| 1992 | 500 Thousand USD | 400.0% |
| 1991 | 100 Thousand USD | 0.0% |
| 1990 | 100 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2022 Q3 | 546 Thousand USD | 85.71% |
| 2022 Q2 | 294 Thousand USD | -8.13% |
| 2022 Q1 | 320 Thousand USD | 880.49% |
| 2021 Q2 | 165 Thousand USD | -56.81% |
| 2021 Q3 | 114 Thousand USD | -30.91% |
| 2021 Q4 | -41 Thousand USD | -135.96% |
| 2021 FY | 620 Thousand USD | 109.46% |
| 2021 Q1 | 382 Thousand USD | 54.66% |
| 2020 Q3 | 241 Thousand USD | 165.67% |
| 2020 Q1 | 175 Thousand USD | 247.06% |
| 2020 Q2 | -367 Thousand USD | -309.71% |
| 2020 Q4 | 247 Thousand USD | 2.49% |
| 2020 FY | 296 Thousand USD | -70.87% |
| 2019 Q3 | -47 Thousand USD | -142.34% |
| 2019 Q1 | 1.07 Million USD | -35.68% |
| 2019 Q4 | -119 Thousand USD | -153.19% |
| 2019 Q2 | 111 Thousand USD | -89.64% |
| 2019 FY | 1.01 Million USD | -86.12% |
| 2018 Q3 | 1.49 Million USD | -46.91% |
| 2018 Q1 | 1.34 Million USD | -51.41% |
| 2018 Q2 | 2.81 Million USD | 108.91% |
| 2018 FY | 7.32 Million USD | -1.67% |
| 2018 Q4 | 1.66 Million USD | 11.45% |
| 2017 Q1 | 1.42 Million USD | 48.74% |
| 2017 FY | 7.44 Million USD | 194.35% |
| 2017 Q4 | 2.77 Million USD | 37.84% |
| 2017 Q3 | 2.01 Million USD | 62.31% |
| 2017 Q2 | 1.23 Million USD | -12.87% |
| 2016 Q3 | 691 Thousand USD | 29.4% |
| 2016 Q4 | 956 Thousand USD | 38.35% |
| 2016 Q1 | 348 Thousand USD | 21.25% |
| 2016 Q2 | 534 Thousand USD | 53.45% |
| 2016 FY | 2.52 Million USD | 447.4% |
| 2015 Q2 | 20 Thousand USD | 266.67% |
| 2015 Q3 | 167 Thousand USD | 735.0% |
| 2015 Q1 | -12 Thousand USD | -176.92% |
| 2015 FY | 462 Thousand USD | 1055.0% |
| 2015 Q4 | 287 Thousand USD | 71.86% |
| 2014 Q3 | 2456.00 USD | -94.99% |
| 2014 FY | 40 Thousand USD | -94.62% |
| 2014 Q1 | 23 Thousand USD | -79.46% |
| 2014 Q2 | 49 Thousand USD | 113.04% |
| 2014 Q4 | 15.6 Thousand USD | 535.18% |
| 2013 Q3 | 224 Thousand USD | -5.49% |
| 2013 Q1 | 169 Thousand USD | -32.94% |
| 2013 FY | 743 Thousand USD | 37.85% |
| 2013 Q4 | 112 Thousand USD | -50.0% |
| 2013 Q2 | 237 Thousand USD | 40.24% |
| 2012 Q3 | 128 Thousand USD | -15.79% |
| 2012 Q2 | 152 Thousand USD | 2071.43% |
| 2012 Q1 | 7000.00 USD | -94.07% |
| 2012 FY | 539 Thousand USD | 120.0% |
| 2012 Q4 | 252 Thousand USD | 96.88% |
| 2011 Q4 | 118 Thousand USD | 1080.0% |
| 2011 FY | 245 Thousand USD | -90.34% |
| 2011 Q2 | 200 Thousand USD | 340.96% |
| 2011 Q1 | -83 Thousand USD | -111.34% |
| 2011 Q3 | 10 Thousand USD | -95.0% |
| 2010 FY | 2.53 Million USD | -2.99% |
| 2010 Q3 | 655 Thousand USD | 0.0% |
| 2010 Q1 | 493 Thousand USD | 30.42% |
| 2010 Q2 | 655 Thousand USD | 32.86% |
| 2010 Q4 | 732 Thousand USD | 11.76% |
| 2009 Q3 | 523 Thousand USD | -30.91% |
| 2009 Q1 | 955 Thousand USD | 10.92% |
| 2009 Q4 | 378 Thousand USD | -27.72% |
| 2009 FY | 2.61 Million USD | -16.52% |
| 2009 Q2 | 757 Thousand USD | -20.73% |
| 2008 Q1 | 763 Thousand USD | 17.38% |
| 2008 FY | 3.13 Million USD | -7.09% |
| 2008 Q4 | 861 Thousand USD | 11.96% |
| 2008 Q3 | 769 Thousand USD | 4.34% |
| 2008 Q2 | 737 Thousand USD | -3.41% |
| 2007 FY | 3.36 Million USD | -23.67% |
| 2007 Q4 | 650 Thousand USD | -24.68% |
| 2007 Q2 | 1.15 Million USD | 65.52% |
| 2007 Q1 | 699 Thousand USD | -31.34% |
| 2007 Q3 | 863 Thousand USD | -25.41% |
| 2006 Q2 | 1.22 Million USD | 1.92% |
| 2006 FY | 4.41 Million USD | -3.41% |
| 2006 Q1 | 1.19 Million USD | 11.13% |
| 2006 Q4 | 1.01 Million USD | 4.2% |
| 2006 Q3 | 977 Thousand USD | -19.98% |
| 2005 FY | 4.57 Million USD | 1.47% |
| 2005 Q4 | 1.07 Million USD | -0.65% |
| 2005 Q3 | 1.08 Million USD | -8.98% |
| 2005 Q1 | 1.21 Million USD | -3.26% |
| 2005 Q2 | 1.19 Million USD | -1.89% |
| 2004 Q3 | 1.05 Million USD | 0.67% |
| 2004 Q2 | 1.04 Million USD | -8.22% |
| 2004 Q1 | 1.14 Million USD | -9.57% |
| 2004 FY | 4.5 Million USD | -9.76% |
| 2004 Q4 | 1.25 Million USD | 18.94% |
| 2003 Q2 | 1.38 Million USD | 26.9% |
| 2003 FY | 4.99 Million USD | 5.16% |
| 2003 Q3 | 1.24 Million USD | -10.09% |
| 2003 Q4 | 1.26 Million USD | 1.36% |
| 2003 Q1 | 1.09 Million USD | -11.93% |
| 2002 Q4 | 1.24 Million USD | 0.89% |
| 2002 FY | 4.74 Million USD | 13.3% |
| 2002 Q3 | 1.23 Million USD | -3.98% |
| 2002 Q2 | 1.28 Million USD | 28.87% |
| 2002 Q1 | 994 Thousand USD | 40.0% |
| 2001 Q4 | 710 Thousand USD | -35.63% |
| 2001 Q3 | 1.1 Million USD | -6.76% |
| 2001 Q2 | 1.18 Million USD | -0.84% |
| 2001 Q1 | 1.19 Million USD | -11.04% |
| 2001 FY | 4.18 Million USD | -39.71% |
| 2000 Q1 | 1.38 Million USD | -45.51% |
| 2000 Q2 | 2.49 Million USD | 80.4% |
| 2000 Q3 | 1.72 Million USD | -30.7% |
| 2000 Q4 | 1.34 Million USD | -22.44% |
| 2000 FY | 6.94 Million USD | -16.67% |
| 1999 Q4 | 2.53 Million USD | 81.29% |
| 1999 Q3 | 1.4 Million USD | -33.33% |
| 1999 Q2 | 2.1 Million USD | 0.0% |
| 1999 Q1 | 2.1 Million USD | -8.7% |
| 1999 FY | 8.33 Million USD | 93.91% |
| 1998 Q1 | 800 Thousand USD | -11.11% |
| 1998 Q3 | 900 Thousand USD | 200.0% |
| 1998 Q4 | 2.3 Million USD | 155.56% |
| 1998 FY | 4.3 Million USD | -23.21% |
| 1998 Q2 | 300 Thousand USD | -62.5% |
| 1997 Q2 | 2.3 Million USD | 91.67% |
| 1997 Q3 | 1.2 Million USD | -47.83% |
| 1997 FY | 5.6 Million USD | -37.78% |
| 1997 Q1 | 1.2 Million USD | -40.0% |
| 1997 Q4 | 900 Thousand USD | -25.0% |
| 1996 Q1 | 3.6 Million USD | -51.35% |
| 1996 Q4 | 2 Million USD | 0.0% |
| 1996 Q3 | 2 Million USD | 53.85% |
| 1996 Q2 | 1.3 Million USD | -63.89% |
| 1996 FY | 9 Million USD | -3.23% |
| 1995 Q2 | 1.5 Million USD | -48.28% |
| 1995 Q3 | 1.6 Million USD | 6.67% |
| 1995 Q4 | 7.4 Million USD | 362.5% |
| 1995 Q1 | 2.9 Million USD | 163.64% |
| 1995 FY | 9.3 Million USD | 244.44% |
| 1994 Q1 | 800 Thousand USD | 300.0% |
| 1994 FY | 2.7 Million USD | 350.0% |
| 1994 Q3 | 300 Thousand USD | -40.0% |
| 1994 Q4 | 1.1 Million USD | 266.67% |
| 1994 Q2 | 500 Thousand USD | -37.5% |
| 1993 Q4 | 200 Thousand USD | 100.0% |
| 1993 FY | 600 Thousand USD | 20.0% |
| 1993 Q1 | 200 Thousand USD | 0.0% |
| 1993 Q2 | 100 Thousand USD | -50.0% |
| 1993 Q3 | 100 Thousand USD | 0.0% |
| 1992 Q4 | - USD | -100.0% |
| 1992 Q1 | - USD | 0.0% |
| 1992 Q3 | 300 Thousand USD | 50.0% |
| 1992 Q2 | 200 Thousand USD | 0.0% |
| 1992 FY | 500 Thousand USD | 400.0% |
| 1991 Q4 | - USD | -100.0% |
| 1991 Q2 | 100 Thousand USD | 0.0% |
| 1991 Q3 | 100 Thousand USD | 0.0% |
| 1991 Q1 | 100 Thousand USD | 0.0% |
| 1991 FY | 100 Thousand USD | 0.0% |
| 1990 FY | 100 Thousand USD | 0.0% |
| 1990 Q3 | 100 Thousand USD | 0.0% |
| 1990 Q2 | 100 Thousand USD | 0.0% |
| 1990 Q1 | 100 Thousand USD | 0.0% |
| 1990 Q4 | - USD | -100.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acutus Medical, Inc. | -3.13 Million USD | 119.764% |
| Cerus Corporation | 86.4 Million USD | 99.282% |
| OrthoPediatrics Corp. | 111.25 Million USD | 99.443% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | 16.163% |
| Talis Biomedical Corporation | 371 Thousand USD | -67.116% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | 92.504% |
| Inogen, Inc. | 126.69 Million USD | 99.511% |
| Spectral AI, Inc. | 7.88 Million USD | 92.132% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 109.405% |
| CVRx, Inc. | 33.03 Million USD | 98.123% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -916.393% |
| Orthofix Medical Inc. | 486.27 Million USD | 99.872% |
| Venus Concept Inc. | 52.16 Million USD | 98.812% |
| Accelerate Diagnostics, Inc. | 2.55 Million USD | 75.686% |
| Bioventus Inc. | 328.19 Million USD | 99.811% |
| BrainsWay Ltd. | 23.09 Million USD | 97.315% |
| Envoy Medical, Inc. | -473 Thousand USD | 231.078% |
| electroCore, Inc. | 13.22 Million USD | 95.312% |
| IceCure Medical Ltd | 1.3 Million USD | 52.308% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 110.248% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 1409.785% |
| MaxCyte, Inc. | 36.54 Million USD | 98.304% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -35.811% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -628.897% |
| PAVmed Inc | -3.96 Million USD | 115.625% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 111.304% |
| RxSight, Inc. | 53.76 Million USD | 98.847% |
| Sight Sciences, Inc. | 69.17 Million USD | 99.104% |
| SI-BONE, Inc. | 109.42 Million USD | 99.433% |
| TELA Bio, Inc. | 40.11 Million USD | 98.454% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | 96.102% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 99.592% |
| LivaNova PLC | 771.25 Million USD | 99.92% |
| 908 Devices Inc. | 25.32 Million USD | 97.552% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 99.8% |
| Nemaura Medical Inc. | -1.47 Million USD | 141.994% |
| NeuroPace, Inc. | 48.12 Million USD | 98.712% |
| LENSAR, Inc. | 21.1 Million USD | 97.063% |
| Apyx Medical Corporation | 14.12 Million USD | 95.61% |
| Cutera, Inc. | 41.49 Million USD | 98.506% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | 96.642% |
| BioSig Technologies, Inc. | 18 Thousand USD | -3344.444% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 99.399% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | 95.446% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 99.93% |
| Axonics, Inc. | 274.55 Million USD | 99.774% |
| Outset Medical, Inc. | 29 Million USD | 97.862% |
| IRIDEX Corporation | 21.8 Million USD | 97.157% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 99.127% |
| IRadimed Corporation | 50.15 Million USD | 98.764% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -116.028% |
| INVO Bioscience, Inc. | 1.08 Million USD | 42.917% |
| Telesis Bio, Inc. | 16.95 Million USD | 96.342% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 99.45% |
| Varex Imaging Corporation | 256.9 Million USD | 99.759% |
| Quipt Home Medical Corp. | 163.84 Million USD | 99.622% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 252.709% |
| Pulmonx Corporation | 50.75 Million USD | 98.778% |
| Dynatronics Corporation | 7.63 Million USD | 91.879% |
| Modular Medical, Inc. | -768 Thousand USD | 180.729% |
| ReShape Lifesciences Inc. | 5.54 Million USD | 88.825% |
| Semler Scientific, Inc. | 61.2 Million USD | 98.987% |
| InMode Ltd. | 411.34 Million USD | 99.849% |
| Bruker Corporation | 1.51 Billion USD | 99.959% |
| Cytosorbents Corporation | 22.39 Million USD | 97.231% |
| DexCom, Inc. | 2.28 Billion USD | 99.973% |
| Align Technology, Inc. | 2.71 Billion USD | 99.977% |
| ZimVie Inc. | 290.38 Million USD | 99.786% |
| Movano Inc. | -158 Thousand USD | 492.405% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 99.433% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -628.897% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 99.831% |
| Profound Medical Corp. | 4.51 Million USD | 86.265% |
| Insulet Corporation | 1.15 Billion USD | 99.947% |
| enVVeno Medical Corporation | -546 Thousand USD | 213.553% |
| Surmodics, Inc. | 93.05 Million USD | 99.334% |
| iCAD, Inc. | 14.53 Million USD | 95.735% |
| Nuwellis, Inc. | 4.98 Million USD | 87.558% |
| Biotricity, Inc. | 8.35 Million USD | 92.58% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 99.813% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 272.675% |
| InspireMD, Inc. | 1.8 Million USD | 65.689% |
| PAVmed Inc. | -3.96 Million USD | 115.625% |
| BIOLASE, Inc. | 16.72 Million USD | 96.293% |
| Beyond Air, Inc. | -1.3 Million USD | 147.437% |
| FONAR Corporation | 45.14 Million USD | 98.626% |
| AxoGen, Inc. | 127.87 Million USD | 99.515% |
| Vivani Medical, Inc. | -357 Thousand USD | 273.669% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 99.682% |
| Inari Medical, Inc. | 434.56 Million USD | 99.857% |
| UFP Technologies, Inc. | 112.22 Million USD | 99.448% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -4852.472% |
| Tenon Medical, Inc. | 1.24 Million USD | 50.04% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 865.432% |
| Co-Diagnostics, Inc. | 2.62 Million USD | 76.4% |
| AdaptHealth Corp. | 479.56 Million USD | 99.871% |
| Sintx Technologies, Inc. | 1.84 Million USD | 66.359% |
| NanoVibronix, Inc. | 1.53 Million USD | 59.662% |
| Quanterix Corporation | 70.64 Million USD | 99.122% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 252.709% |
| Sensus Healthcare, Inc. | 14.06 Million USD | 95.59% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 98.825% |
| TransMedics Group, Inc. | 154.09 Million USD | 99.598% |
| ReWalk Robotics Ltd. | 4.45 Million USD | 86.077% |
| NeuroMetrix, Inc. | 3.94 Million USD | 84.294% |
| Hyperfine, Inc. | 4.75 Million USD | 86.967% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 99.42% |
| Biomerica, Inc. | 611 Thousand USD | -1.473% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 98.513% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 179.39% |
| Silk Road Medical, Inc | 127.08 Million USD | 99.512% |